Your browser doesn't support javascript.
loading
Examining patient demographics and major adverse cardiac events following noncardiac surgery: Applying a health equity lens.
Herrera-Quiroz, Demian; Smith, Bradford B; Dodoo, Christopher; Brown, Michael J; Hayes, Sharonne N; Milam, Adam J.
Afiliação
  • Herrera-Quiroz D; Mayo Clinic Alix School of Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Smith BB; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ 85054, USA.
  • Dodoo C; Department of Quantitative Health Sciences, Mayo Clinic; Phoenix, AZ 85054, USA.
  • Brown MJ; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
  • Hayes SN; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
  • Milam AJ; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Phoenix, AZ 85054, USA; Department of Quantitative Health Sciences, Mayo Clinic; Phoenix, AZ 85054, USA. Electronic address: milam.adam@mayo.edu.
Article em En | MEDLINE | ID: mdl-38876941
ABSTRACT

BACKGROUND:

Major adverse cardiac events (MACE) are a major contributor to postoperative complications. This study employed a health equity lens to examine rates of postoperative MACE by race and ethnicity.

METHODS:

This single-center, retrospective observational cohort study followed patients with and without pre-existing coronary artery stents from 2008 to 2018 who underwent non-cardiac surgery. MACE was the primary outcome (death, acute MI, repeated coronary revascularization, in-stent thrombosis) and self-reported race and ethnicity was the primary predictor. A propensity score model of a 11 cohort of non-Hispanic White (NHW) patients and all other racial and ethnic minority populations (Hispanic and Black) was used to compare the rate of perioperative MACE in this cohort.

RESULTS:

During the study period, 79,686 cases were included in the analytic sample; 950 patients (1.2 %) had pre-existing coronary artery stents. <1 % of patients experienced MACE within 30 days following non-cardiac surgery (0.8 %). After confounder adjustment and propensity score matching, there were no statistically significant differences in MACE among racial and ethnic minority patients compared to NHW patients (OR = 0.77; 95 % CI 0.48, 1.25). In our sensitivity analyses, stratifying by sex, there were no differences in MACE by race and ethnicity.

CONCLUSIONS:

The study found no statistically significant differences in MACE by race and ethnicity among patients who underwent non-cardiac surgery. Access to a high-volume, high-quality hospital such as the one studied may reduce the presence of healthcare disparities and may explain why our findings are not consistent with previous studies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cardiovasc Revasc Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cardiovasc Revasc Med Ano de publicação: 2024 Tipo de documento: Article